Your browser doesn't support javascript.
loading
Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series.
van der Mijn, Johannes C; Al Hussein Al Awamlh, Bashir; Islam Khan, Aleem; Posada-Calderon, Lina; Oromendia, Clara; Fainberg, Jonathan; Alshak, Mark; Elahjji, Rahmi; Pierce, Hudson; Taylor, Benjamin; Gudas, Lorraine J; Nanus, David M; Molina, Ana M; Del Pizzo, Joseph; Scherr, Douglas S.
Afiliação
  • van der Mijn JC; Department of Pharmacology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Al Hussein Al Awamlh B; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Islam Khan A; Department of Urology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Posada-Calderon L; Department of Urology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Oromendia C; Department of Urology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Fainberg J; Department of Biostatistics and Epidemiology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Alshak M; Department of Urology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Elahjji R; Department of Urology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Pierce H; Department of Urology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Taylor B; Department of Urology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Gudas LJ; Department of Urology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Nanus DM; Department of Pharmacology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Molina AM; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Del Pizzo J; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
  • Scherr DS; Department of Urology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.
PLoS One ; 14(12): e0226285, 2019.
Article em En | MEDLINE | ID: mdl-31815952
ABSTRACT

PURPOSE:

To validate prognostic factors and determine the impact of obesity, hypertension, smoking and diabetes mellitus (DM) on risk of recurrence after surgery in patients with localized renal cell carcinoma (RCC). MATERIALS AND

METHODS:

We performed a retrospective cohort study among patients that underwent partial or radical nephrectomy at Weill Cornell Medicine for RCC and collected preoperative information on RCC risk factors, as well as pathological data. Cases were reviewed for radiographic evidence of RCC recurrence. A Cox proportional-hazards model was developed to determine the contribution of RCC risk factors to recurrence risk. Disease-free survival and overall survival were analyzed using the Kaplan-Meier method and log-rank test.

RESULTS:

We identified 873 patients who underwent surgery for RCC between the years 2000-2015. In total 115 patients (13.2%) experienced a disease recurrence after a median follow up of 4.9 years. In multivariate analysis, increasing pathological T-stage (HR 1.429, 95% CI 1.265-1.614) and Nuclear grade (HR 2.376, 95% CI 1.734-3.255) were independently associated with RCC recurrence. In patients with T1-2 tumors, DM was identified as an additional independent risk factor for RCC recurrence (HR 2.744, 95% CI 1.343-5.605). Patients with DM had a significantly shorter median disease-free survival (1.5 years versus 2.6 years, p = 0.004), as well as median overall survival (4.1 years, versus 5.8 years, p<0.001).

CONCLUSIONS:

We validated high pathological T-stage and nuclear grade as independent risk factors for RCC recurrence following nephrectomy. DM is associated with an increased risk of recurrence among patients with early stage disease.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Diabetes Mellitus / Neoplasias Renais / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Diabetes Mellitus / Neoplasias Renais / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos